Vaccine Market Overview in Austria
In value terms, vaccine production stood at $ in 2019 estimated in export prices. Overall, production, however, recorded a mild curtailment. The most prominent rate of growth was recorded in 2013 with an increase of % y-o-y. Vaccine production peaked at $ in 2008; however, from 2009 to 2019, production failed to regain the momentum.
The revenue of the vaccine market in Austria rose modestly to $ in 2019, growing by % against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Over the period under review, consumption continues to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2016 with an increase of % year-to-year. As a result, consumption reached the peak level of $. From 2017 to 2019, the growth of the market failed to regain the momentum.